84 results match your criteria: "Kasukabe-chuo General Hospital[Affiliation]"
Eur J Dermatol
October 2024
Department of Dermatology, Jichi Medical University Saitama Medical Center, Saitama 330-0834, Japan.
JPRAS Open
December 2024
Limb Salvage Center, Kasukabe Chuo General Hospital, 344-0063 midori5-9-4, Kasukabe, Saitama, Japan.
Background: Patients with chronic limb-threatening ischemia experience long-duration pain during ulcer treatment. Hence, painkillers are gradually increased, but adverse events often occur. Spinal cord stimulation trial is one of the methods used to manage such pain.
View Article and Find Full Text PDFEur J Vasc Endovasc Surg
November 2024
Department of Vascular Surgery, Asahikawa Medical University, Asahikawa, Japan.
Objective: This study aimed to determine the impact of infrapopliteal (IP) revascularisation establishing in line flow to the wound (IFW) on wound healing in chronic limb threatening ischaemia (CLTI), using a core laboratory assessment for wounds and in line flow.
Methods: The Wound directed Angiosome RevasculaRIsation apprOach to patients with cRitical limb iSchaemia (WARRIORS) multicentre observational study enrolled patients with CLTI with tissue loss undergoing IP revascularisation in Japan, with scheduled two year follow up. The primary outcome measure was complete wound healing, defined as achievement of complete epithelialisation of all wounds without major amputation.
J Vasc Surg
December 2024
Department of Cardiology, Tokeidai Memorial Hospital, Sapporo, Japan.
Objective: To evaluate the healing outcome of a platelet-rich plasma (PRP) gel prepared using TKKT01 (a wound care device to prepare the PRP gel) in patients with hard-to-heal diabetic foot ulcers (DFUs) and who showed an inadequate response to ≥4 weeks of standard of care (SoC).
Method: This open-label, single-arm, multicentre study was conducted in 15 centres in Japan. Eligible patients received PRP gel treatment twice a week for eight weeks, followed by a final evaluation after the completion of week 8 (day 57).
JACC Adv
November 2023
Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Cardiovasc Intervent Radiol
June 2024
Division of Minimally Invasive Treatment in Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Purpose: In the present trial, the 24-month safety and effectiveness of the TCD-17187 drug-coated balloon (DCB) for the treatment of atherosclerotic lesions in the superficial femoral artery (SFA) and proximal popliteal artery (PA) were evaluated in Japanese patients.
Methods: This was a prospective, multicenter, core laboratory-adjudicated, single-arm trial. From 2019 to 2020, 121 patients with symptomatic peripheral artery disease were enrolled.
Int Heart J
March 2024
Division of Cardiovascular Medicine, Toho University Ohashi Medical Center.
Plast Reconstr Surg Glob Open
February 2024
From the Limb Salvage Center, Kasukabe Chuo General Hospital, Saitama, Japan.
Background: Chronic limb-threatening ischemia (CLTI) is a severe peripheral artery disease with rest pain and lower limb ulceration. After revascularization, limb ulceration treatment should be completed quickly before restenosis. We aimed to investigate the effect of negative pressure wound therapy with instillation and dwell (NPWTi-d) using an antiseptic solution (AS) versus a saline solution (SS) in CLTI.
View Article and Find Full Text PDFClin Case Rep
August 2023
Department of System Design Engineering, Faculty of Science and Technology Keio University Yokohama Japan.
This case highlights the biomechanical influence of toe amputation on contralateral limb force elevation, possibly through reduced ipsilateral plantar flexor torque production. These findings provide insight into toe amputation-related compensatory gait mechanics with greater inter-limb asymmetry, which may increase the risk of musculoskeletal comorbidities, including osteoarthritis in contralateral limb.
View Article and Find Full Text PDFCVIR Endovasc
August 2023
Department of Cardiovascular Medicine, Ichinomiya Nishi Hospital, Aichi, Japan.
Background: Drug-coated balloons (DCBs) have significantly changed endovascular therapy (EVT) for femoropopliteal artery (FPA) disease, in terms of the expansion of indications for EVT for symptomatic lower extremity arterial disease (LEAD). However, whether there is a difference in the performance among individual DCBs has not yet been fully discussed. The present sub-analysis of real-world data from a prospective trial of first-generation DCBs compared the clinical outcomes between high- and low-dose DCBs using propensity score matching methods.
View Article and Find Full Text PDFBMJ Open
July 2023
Human Health Sciences, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, Japan
Innov Aging
June 2023
Center for Innovative Research for Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima, Japan.
Int J Low Extrem Wounds
July 2023
Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Hyogo, Japan.
Rehabilitation is usually provided to patients with chronic foot wounds (CFWs) after surgery. This study aimed to assess whether early postoperative rehabilitation could maintain walking independence in hospitalized patients with CFWs. This single-blind, randomized clinical trial was performed between September 10, 2018 and March 2019, involving 60 patients who underwent both surgical procedures and rehabilitation.
View Article and Find Full Text PDFCochrane Database Syst Rev
December 2022
Department of Psychiatry, Soseikai General Hospital, Kyoto, Japan.
Background: Carnitine deficiency is common in patients with chronic kidney disease (CKD) who require dialysis. Several clinical studies have suggested that carnitine supplementation is beneficial for dialysis-related symptoms. However, the clinical effectiveness and potential adverse effects of carnitine supplementation in dialysis patients have not been determined.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2022
Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Purpose: The aim of this preapproval trial was to evaluate the 12-month safety and effectiveness of the TCD-17187 drug-coated balloon (DCB) for the treatment of atherosclerotic lesions in the superficial femoral artery (SFA) and/or proximal popliteal artery (PA).
Methods: This was a prospective, multicenter, core laboratory adjudicated, single-arm trial. From October 2019 to November 2020, a total of 121 symptomatic peripheral artery disease patients with SFA and/or proximal PA lesions were enrolled.
Heart Vessels
January 2023
Department of Cardiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
Peripheral artery disease (PAD) and atrial fibrillation (AF) are associated with major cardiovascular and cerebrovascular events (MACCE). However, outcomes stratified according to the preoperative symptoms of PAD in patients with AF have not been sufficiently investigated. This was a retrospective study of prospectively collected data pertaining to 2237 patients (1179 patients with intermittent claudication [IC] and 1058 patients with critical limb-threatening ischemia [CLTI]) who underwent endovascular therapy at 34 hospitals between August 2014 and August 2016.
View Article and Find Full Text PDFBMC Geriatr
July 2022
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Int J Surg Case Rep
June 2022
Limb Salvage Center, Kasukabe Chuo General Hospital, 344-0063 midori5-9-4, Kasukabe, Saitama, Japan.
Introduction And Importance: Chronic limb-threatening ischemia (CLTI) is a severe limb problem. The causes of foot ulcer are influenced by several factors, which lead to ischemia and foot deformity causing recurrence after wound healing. This report focuses on the long-term course.
View Article and Find Full Text PDFBMJ Case Rep
April 2022
Heart Center, Kasukabe Chuo General Hospital, Kasukabe, Japan.
Man in his 30s was diagnosed with type B acute aortic dissection with malperfusion syndrome. Emergent endovascular therapy assisted by intravascular ultrasound was performed due to the unavailability of the neighbourhood cardiovascular surgeons and stored stent grafts. Stenting at the dissected superior mesenteric artery resolved the malperfusion syndrome.
View Article and Find Full Text PDFESC Heart Fail
June 2022
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Sci Rep
February 2022
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Although postural hypotension (PH) is reportedly associated with mortality in the general population, the prognostic value for heart failure is unclear. This was a post-hoc analysis of FRAGILE-HF, a prospective multicenter observational study focusing on frailty in elderly patients with heart failure. Overall, 730 patients aged ≥ 65 years who were hospitalized with heart failure were enrolled.
View Article and Find Full Text PDFCardiovasc Interv Ther
October 2022
Heart Center, Kasukabe Chuo General Hospital, 5-9-4 Midori-cho, Kasukabe, Saitama, 344-0063, Japan.
ESC Heart Fail
April 2022
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Aims: A patient's understanding of his or her own comorbidities is part of the recommended patient education for those with heart failure. The accuracy of patients' understanding of their comorbidities and its prognostic impact have not been reported.
Methods And Results: Patients hospitalized for heart failure (n = 1234) aged ≥65 years (mean age: 80.
Nutr Metab Cardiovasc Dis
February 2022
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo, Japan.